These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26049048)

  • 1. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Rosenthal L; Fananapazir L; Gleva M; Mazur A; Rinaldi CA; Kypta A; Merkely B; Woodard PK;
    Heart Rhythm; 2015 Jun; 12(6):1183-91. PubMed ID: 25680307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
    Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
    Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.
    Rinaldi CA; Vitoff PJ; Nair DG; Bernstein R; Mountantonakis SE; Rapacciuolo A; Carter N; Tse HF; Green UB
    Heart Rhythm; 2020 Dec; 17(12):2064-2071. PubMed ID: 32911050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
    Gold MR; Sommer T; Schwitter J; Al Fagih A; Albert T; Merkely B; Peterson M; Ciuffo A; Lee S; Landborg L; Cerkvenik J; Kanal E;
    J Am Coll Cardiol; 2015 Jun; 65(24):2581-2588. PubMed ID: 25982014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in patients with cardiac implantable electronic devices: a single-center prospective study.
    Yadava M; Nugent M; Krebsbach A; Minnier J; Jessel P; Henrikson CA
    J Interv Card Electrophysiol; 2017 Oct; 50(1):95-104. PubMed ID: 28733766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of magnetic resonance imaging on ventricular tachyarrhythmia sensing: Results of the Evera MRI Study.
    Gold MR; Sommer T; Schwitter J; Kanal E; Bernabei MA; Love CJ; Surber R; Ramza B; Cerkvenik J; Merkely B
    Heart Rhythm; 2016 Aug; 13(8):1631-5. PubMed ID: 27196818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Safety for Patients Implanted With the MRI Ready ICD System: MRI Ready Study Results.
    Nazarian S; Cantillon DJ; Woodard PK; Mela T; Cline AM; Strickberger AS;
    JACC Clin Electrophysiol; 2019 Aug; 5(8):935-943. PubMed ID: 31439295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.
    Sheldon SH; Bunch TJ; Cogert GA; Acker NG; Dalzell CM; Higgins JV; Espinosa RE; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Anderson JL; Brooks MH; Osborn JS; Friedman PA
    Heart Rhythm; 2015 Feb; 12(2):345-9. PubMed ID: 25433144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use.
    Gold MR; Kanal E; Schwitter J; Sommer T; Yoon H; Ellingson M; Landborg L; Bratten T
    Heart Rhythm; 2015 Mar; 12(3):631-638. PubMed ID: 25496984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator.
    Keller J; Neužil P; Vymazal J; Janotka M; Brada J; Žáček R; Vopálka R; Weichet J; Reddy VY
    Europace; 2015 May; 17(5):761-6. PubMed ID: 25687749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
    Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.
    Weiss R; Knight BP; Gold MR; Leon AR; Herre JM; Hood M; Rashtian M; Kremers M; Crozier I; Lee KL; Smith W; Burke MC
    Circulation; 2013 Aug; 128(9):944-53. PubMed ID: 23979626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.